Home » Reports » Broker Ratings » Smith & Nephew plc 2.7% Potential Decrease Indicated by JP Morgan Cazenove

Smith & Nephew plc 2.7% Potential Decrease Indicated by JP Morgan Cazenove

Smith & Nephew plc with EPIC/TICKER (LON:SN) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘NEUTRAL’ today by analysts at JP Morgan Cazenove. Smith & Nephew plc are listed in the Health Care sector within UK Main Market. JP Morgan Cazenove have set a target price of 1926 GBX on its stock. This would indicate that the analyst believes there is a downside of -2.7% from today’s opening price of 1979.5 GBX. Over the last 30 and 90 trading days the company share price has increased 83 points and increased 272 points respectively. The 1 year high stock price is 2023 GBX while the year low share price is currently 1417 GBX.

Smith & Nephew plc has a 50 day moving average of 1,870.11 GBX and a 200 Day Moving Average share price is recorded at 1,813.10. There are currently 875,195,533 shares in issue with the average daily volume traded being 1,914,006. Market capitalisation for LON:SN is £17,060,501,250 GBP.

Join us on our new LinkedIn page

Follow us on LinkedIn